OrganOx and eGenesis Announce Exclusive Clinical Co-Development Agreement for Treatment of Patients with Liver Failure in the Acute Setting OrganOx and eGenesis Announce Exclusive Clinical Co-Development Agreement for Treatment of Patients with Liver Failure in the Acute Setting

OrganOx metra® System Approved for Liver Transplantation in Canada OrganOx metra® System Approved for Liver Transplantation in Canada

Appointment of Stephen M. Deitsch as new Chief Financial Officer OrganOx Appoints Stephen M. Deitsch, an experienced medtech finance leader with proven track record with IPOs, as new Chief Financial Officer.

OrganOx Raises £25 Million in Growth Round Led by Lauxera Capital Partners OXFORD, United Kingdom, July 17, 2023 (GLOBE NEWSWIRE) -- OrganOx Ltd (“OrganOx” or the “Company”), a world-leading medical technology company committed to making every donated organ count with...